The 3 analysts offering 12-month price forecasts for Alimera Sciences Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 8.00. The median estimate represents a +93.66% increase from the last price of 5.68.
The current consensus among 3 polled investment analysts is to Buy stock in Alimera Sciences Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.67
Reporting Date Aug 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.